-+ 0.00%
-+ 0.00%
-+ 0.00%

Raymond James Maintains Outperform on Oscar Health, Raises Price Target to $42

Benzinga·09/18/2026 12:09:13
Listen to the news
Raymond James analyst John Ransom maintains Oscar Health (NYSE:OSCR) with a Outperform and raises the price target from $34 to $42.